image
Pasithea Therapeutics Corp. KTTA
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.565
3.62 %
$ 4.23 M
Market Cap
-0.11
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
--29.29%
Net Income Estimate
--2725.42%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Pasithea Therapeutics Corp.
image
KTTA has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart KTTA

image
$500.0k$500.0k$450.0k$450.0k$400.0k$400.0k$350.0k$350.0k$300.0k$300.0k$250.0k$250.0k$200.0k$200.0k$150.0k$150.0k$100.0k$100.0k$50.0k$50.0k$0.0$0.0202120212022202220232023
EBIT FORECAST

EBIT Forecast Chart KTTA

image
$0.0$0.0($2.0b)($2.0b)($4.0b)($4.0b)($6.0b)($6.0b)($8.0b)($8.0b)($10.0b)($10.0b)($12.0b)($12.0b)($14.0b)($14.0b)($16.0b)($16.0b)202120212022202220232023
NET INCOME FORECAST

Net Income Chart KTTA

image
$0.0$0.0($2.0b)($2.0b)($4.0b)($4.0b)($6.0b)($6.0b)($8.0b)($8.0b)($10.0b)($10.0b)($12.0b)($12.0b)($14.0b)($14.0b)202120212022202220232023